A three-year study of GA Depot, a monthly injection for primary progressive multiple sclerosis (PPMS), found that most patients…
Articles by Marisa Wexler, MS
A new study suggests that how certain immune cells respond to Mavenclad (cladribine) may help explain why…
Years before a diagnosis of multiple sclerosis (MS), people who later develop the disease have more doctor visits and…
Oligodendrocytes, the cells responsible for making myelin, are constantly being made throughout the brain and spinal cord, even when…
Treatment with the nasal spray therapy foralumab stabilized disability over six months in all 10 people with nonactive secondary…
When immune B-cells mistakenly recognize the body’s own nerve tissue, they can shut themselves down to prevent damage, but infection…
People whose biological mothers had diabetes during pregnancy are more likely to develop multiple sclerosis (MS) as adults, according…
A new machine learning tool can now help predict whether people newly diagnosed with multiple sclerosis (MS) will experience…
A history of the Epstein-Barr virus (EBV) appears to alter the immune systems of people with specific genetic traits,…
People with multiple sclerosis (MS) who have mild disability still experience several disease-related difficulties at work — challenges that…
A group of international experts has proposed a first-of-its-kind framework aimed at preventing multiple sclerosis (MS) from developing. Rather…
Inflammatory gut bacteria that carry proteins structurally similar to myelin, a protective layer surrounding nerve fibers that is damaged in…
Multiple sclerosis (MS) may follow two distinct biological paths that differ in how early and how quickly nerve damage…
The balance between two immune signaling molecules — CXCL13 and BAFF — may help identify the hard-to-treat inflammation in the…
The National Institute for Health and Care Excellence (NICE) in England is recommending natalizumab — sold as Tysabri and…
Quantum Biopharma has completed dosing in two toxicology studies requested by the U.S. Food and Drug Administration (FDA) that…
Throughout 2025, the team at Multiple Sclerosis News Today brought our readers the latest advances and updates in research related…
After months of delay, the U.S. Food and Drug Administration (FDA) has rejected Sanofi‘s application seeking approval of…
Disability progression in relapsing forms of multiple sclerosis (MS) tends to follow one of four distinct patterns, according to…
Myelin, the protective coating that helps nerve signals travel quickly and efficiently, also plays a key role in the precise…
A clinical trial testing whether music therapy can make botulinum toxin injections for spasticity more tolerable for people with…
Following negative Phase 3 trial results, Sanofi announced that it will not be pursuing approval of its experimental therapy…
A signaling molecule called erythropoietin (EPO) plays a key role in allowing the immune system to distinguish the body’s own…
A few months ago in Barcelona, at the annual conference of the European Committee for Treatment and Research in Multiple…
Disability progression is not always permanent for people with relapsing-remitting multiple sclerosis (RRMS), even when it occurs independent of…
Oligodendrocytes, the cells that build and repair myelin in the brain and spinal cord, may play a role in the…
Simultaneously measuring levels of two blood proteins — glial fibrillary acidic protein (GFAP) and neurofilament light chain (NfL)…
A Phase 2 clinical trial testing PIPE-307, an experimental therapy designed to support myelin repair in people with multiple…
A clinical trial is now recruiting participants to test whether an experimental vaccine for the Epstein-Barr virus (EBV) is…
Mesenchymal stem cell therapy shows promise for treating multiple sclerosis (MS), with improvements seen in disability, walking ability,…